Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,289,093 papers from all fields of science
Search
Sign In
Create Free Account
123I-IBZM
Known as:
Iodine I 123 Iodobenzamide
A radiopharmaceutical containing the dopamine D2/D3 receptor agonist iodobenzamide (IBZM) labeled with the radionuclide iodine I 123 with dopamine…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Schizotypy trait and striatal dopamine receptors in healthy volunteers
K. Chen
,
I. Lee
,
+5 authors
Chwen-Cheng Chen
Psychiatry Research: Neuroimaging
2012
Corpus ID: 30588354
2008
2008
Test–retest variability and reliability of 123I‐IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms
A. Catafau
,
S. Bullich
,
+6 authors
D. Ros
Synapse
2008
Corpus ID: 21284964
Objective: 123I‐IBZM single photon emission computed tomography (SPECT) is a widely used method to measure D2 receptor…
Expand
Review
2007
Review
2007
Diagnostic imaging of dopamine receptors in pituitary adenomas.
W. D. de Herder
,
A. Reijs
,
+4 authors
D. Kwekkeboom
European Journal of Endocrinology
2007
Corpus ID: 24851105
Dopamine D2 receptor scintigraphy of pituitary adenomas is feasible by single-photon emission computed tomography using (123)I-S…
Expand
2004
2004
Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study
F. Lomeña
,
A. Catafau
,
+4 authors
J. Pavía
Psychopharmacology
2004
Corpus ID: 52324
Most post-mortem autoradiographic studies have described striatal dopamine D2 receptor up-regulation due to chronic neuroleptic…
Expand
2003
2003
Preliminary evidence of striatal D2 receptor density as a possible biological marker of prognosis in naive schizophrenic patients
V. Pérez
,
A. Catafau
,
I. Corripio
,
Juan Carlos Martıx0301n
,
E. Alvarez
Progress in Neuro-psychopharmacology and…
2003
Corpus ID: 8656340
2000
2000
Diagnosis of Hallervorden-Spatz Disease Using MRI, 123I-Beta-CIT-SPECT and 123I-IBZM-SPECT
W. Hermann
,
M. Reuter
,
H. Barthel
,
J. Dietrich
,
P. Georgi
,
A. Wagner
European Neurology
2000
Corpus ID: 35885766
Hallervorden-Spatz disease (HSD), a rare extrapyramidal motor illness with familial aggregation or sporadic appearance, is…
Expand
Highly Cited
1998
Highly Cited
1998
123I‐IBZM binding compared with long‐term clinical follow up in patients with de novo parkinsonism
J. Schwarz
,
K. Tatsch
,
+4 authors
W. Oertel
Movement Disorders
1998
Corpus ID: 23486843
We performed a prospective clinical follow up (mean follow up, 36 months; range, 24–56 months) of 65 patients with de novo…
Expand
1997
1997
Registration of dynamic dopamine D2 receptor images using principal component analysis
P. Acton
,
L. Pilowsky
,
J. Suckling
,
M. Brammer
,
P. Ell
European Journal of Nuclear Medicine
1997
Corpus ID: 19922601
Abstract.This paper describes a novel technique for registering a dynamic sequence of single-photon emission tomography (SPET…
Expand
Highly Cited
1993
Highly Cited
1993
Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
N. Verhoeff
,
O. Kapucu
,
E. Sokole-Busemann
,
E. V. Royen
,
Agm Janssen
Journal of Nuclear Medicine
1993
Corpus ID: 20516561
Factors contributing to the quantification of the striatal dopamine D2 receptor binding potential in vivo using 123I…
Expand
1993
1993
Dopamine D2 receptor SPECT imaging: Basicin vivo characteristics and clinical applications of123I-IBZM in humans
H. Toyama
,
M. Ichise
,
J. Ballinger
,
L. Fornazzari
,
J. Kirsh
1993
Corpus ID: 73120906
The purposes of this study are to evaluate the utility of kit formulation, the basicin vivo characteristics, and clinical…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE